Your browser doesn't support javascript.
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.
Iacoboni, Gloria; Rejeski, Kai; Villacampa, Guillermo; van Doesum, Jaap A; Chiappella, Annalisa; Bonifazi, Francesca; Lopez-Corral, Lucia; van Aalderen, Michiel; Kwon, Mi; Martínez-Cibrian, Nuria; Bramanti, Stefania; Reguera-Ortega, Juan Luis; Camacho-Arteaga, Lina; Schmidt, Christian; Marín-Niebla, Ana; Kersten, Marie José; Martin Garcia-Sancho, Alejandro; Zinzani, Pier Luigi; Corradini, Paolo; van Meerten, Tom; Subklewe, Marion; Barba, Pere.
  • Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Rejeski K; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Villacampa G; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • van Doesum JA; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Chiappella A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Bonifazi F; The Institute of Cancer Research, London, United Kingdom.
  • Lopez-Corral L; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Aalderen M; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy.
  • Kwon M; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Martínez-Cibrian N; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Bramanti S; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.
  • Reguera-Ortega JL; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
  • Camacho-Arteaga L; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Schmidt C; Gregorio Marañón Health Research Institute, Madrid, Spain.
  • Marín-Niebla A; Department of Hematology, Hospital Clinic, Barcelona, Spain.
  • Kersten MJ; Istituto Clinico Humanitas IRCCS, Rozzano, Italy.
  • Martin Garcia-Sancho A; Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain.
  • Zinzani PL; Clinical Pharmacology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Corradini P; Clinical Pharmacology, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • van Meerten T; Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Barcelona, Spain; and.
  • Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Blood Adv ; 6(12): 3606-3610, 2022 06 28.
Article in English | MEDLINE | ID: covidwho-1916905
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Mantle-Cell / Antineoplastic Agents Limits: Adult / Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021006922

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Mantle-Cell / Antineoplastic Agents Limits: Adult / Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021006922